Changes in the Concentrations of Proangiogenic Cytokines in Human Brain Glioma and Acute Lymphoblastic Leukemia

Author:

Oldak Lukasz1ORCID,Zielinska Zuzanna2ORCID,Milewska Patrycja3,Chludzinska-Kasperuk Sylwia3,Latoch Eryk4ORCID,Konończuk Katarzyna4ORCID,Krawczuk-Rybak Maryna4,Starosz Aleksandra5ORCID,Grubczak Kamil5ORCID,Reszeć Joanna36,Gorodkiewicz Ewa1

Affiliation:

1. Bioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland

2. Doctoral School of Exact and Natural Science, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland

3. Biobank, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland

4. Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Bialystok, Poland

5. Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland

6. Department of Medical Pathology, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland

Abstract

Acute lymphoblastic leukemia (ALL) and glioma are some of the most common malignancies, with ALL most often affecting children and glioma affecting adult men. Proangiogenic cytokines and growth factors play an important role in the development of both of these tumors. Glioma is characterized by an extremely extensive network of blood vessels, which continues to expand mainly in the process of neoangiogenesis, the direct inducers of which are cytokines from the family of vascular endothelial growth factors, i.e., vascular endothelial growth factor (VEGF-A) and its receptor vascular endothelial growth factor receptor 2 (VEGF-R2), as well as a cytokine from the fibroblast growth factor family, fibroblast growth factor 2 (FGF-2 or bFGF). Growth factors are known primarily for their involvement in the progression and development of solid tumors, but there is evidence that local bone marrow angiogenesis and increased blood vessel density are also present in hematological malignancies, including leukemias. The aim of this study was to examine changes in the concentrations of VEGF-A, VEGF-R2, and FGF-2 (with a molecular weight of 17 kDa) in a group of patients divided into specific grades of malignancy (glioma) and a control group; changes of VEGF-A and FGF-2 concentrations in childhood acute lymphoblastic leukemia and a control group; and to determine correlations between the individual proteins as well as the influence of the patient’s age, diet, and other conditions that may place the patient in the risk group. During the statistical analysis, significant differences in concentrations were found between the patient and control groups in samples from people with diagnosed glioma and from children with acute lymphoblastic leukemia, but in general, there are no significant differences in the concentrations of VEGF-A, VEGF-R2, and FGF-2 between different grades of glioma malignancy. Among individuals treated for glioma, there was no significant impact from the patient’s gender and age, consumption of food from plastic packaging, frequency of eating vegetables and fruit, smoking of tobacco products, the intensity of physical exercise, or the general condition of the body (Karnofsky score) on the concentrations of the determined cytokines and receptor. The listed factors do not bring about an actual increase in the risk of developing brain glioma.

Funder

Polish Ministry of Science and Higher Education

Medical University of Bialystok

Publisher

MDPI AG

Reference38 articles.

1. Acute Lymphoblastic Leukemia;Onciu;Hematol. Oncol. Clin. N. Am.,2009

2. Obesity in Patients with Acute Lymphoblastic Leukemia in Childhood;Iughetti;Ital. J. Pediatr.,2012

3. Rates and Trends of Childhood Acute Lymphoblastic Leukaemia: An Epidemiology Study;Kakaje;Sci. Rep.,2020

4. Cancers of the Brain and CNS: Global Patterns and Trends in Incidence;Soerjomataram;Neuro-Oncology,2017

5. Evaluation of VEGF, FGF and PDGF and Serum Levels of Inflammatory Cytokines in Patients with Glioma and Meningioma in Southern Iran;Shamsdin;Asian Pac. J. Cancer P.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3